Journals / The Anatolian Journal of Cardiology / 2017 / Cilt: 18 - Sayı: 5

Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention ( Author`s Reply)

Pages
377–377
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

BAE, J. S., AHN, J., JEONG, Y. (2017). Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention ( Author`s Reply). The Anatolian Journal of Cardiology, Cilt: 18 - Sayı: 5, 377–377. https://ajindex.com/articles/365403

References (5)

  1. Jeong YH, Ahn JH, Shin ES. Impact of high on-treatment platelet reactivity on long-term clinical events in AMI patients: a fact or mirage? Anatol J Cardiol 2016 Nov 16. Epub ahead of print
  2. Zhou Y, Wang Y, Wu Y, Huang C, Yan H, Zhu W, et al. Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a metaanalysis of randomized controlled trials. BMC Cardiovasc Disord 2017; 17: 157
  3. Jeong YH, Tantry US, Gurbel P. What is the “East Asian Paradox”? Cardiosource Interventional News 2012; 1: 38-9
  4. Levine GN, Jeong YH, Goto S, Anderson JL, Huo Y, Mega JL, et al. Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Nat Rev Cardiol 2014; 11: 597-606
  5. Gijsberts CM, den Ruijter HM, Asselbergs FW, Chan MY, de Kleijn DP, Hoefer IE. Biomarkers of Coronary Artery Disease Differ Between Asians and Caucasians in the General Population. Glob Heart 2015; 10: 301-311.e11.